I want assistance with preparing a paper on Sanofi-Aventis marketing their pharmaceutical products in China. I only need assistance with the final two parts:
1. FDA remarks or obstacles and validity, equivalency when it comes to comparable US drugs
2. How process can affect US pharmaceutical industry and pharmaceutical pricing.
I have also been trying to find graphs about Sanofi-Aventis before and after the entrance into China.